OFFICIAL LEGAL TITLE
Agility in Manufacturing Preparedness Act
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_S_3553.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2022-02-02.
What are the main provisions?
Key points include:
- Reviewing current US drug manufacturing capabilities to identify weaknesses.
- Developing plans and technologies for rapid production adaptation to new threats.
- Strengthening domestic drug production, reducing reliance on foreign suppliers in critical times.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Rubio, Marco [R-FL].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.